Related Experiment Videos
Control of heme reactivity by diffusion: structural basis and functional characterization in hemoglobin mutants
A E Miele1, F Draghi, A Arcovito
1Department of Biochemical Sciences "A. Rossi Fanelli" and CNR Centre for Molecular Biology, University of Rome "La Sapienza", P.le A. Moro 5, 00185 Rome, Italy.
Biochemistry
|November 29, 2001
Summary
Mutagenesis of human hemoglobin alters oxygen, carbon monoxide, and nitric oxide binding. These engineered hemoglobin mutants show reduced ligand affinity, a key step toward developing hemoglobin-based blood substitutes.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Hemoglobin solutions are explored as blood substitutes, but their reactivity hinders clinical use.
- Understanding ligand binding kinetics is crucial for modifying hemoglobin's properties.
Purpose of the Study:
- Investigate the impact of specific mutations on human hemoglobin's O(2), CO, and NO binding.
- Design hemoglobin mutants with altered reactivity for potential blood substitute applications.
Main Methods:
- Site-directed mutagenesis of human hemoglobin at positions B10 and E7.
- Kinetic analysis of ligand binding (O(2), CO, NO).
- High-resolution crystallography of mutant hemoglobins.
Main Results:
- Mutations at B10 (Leu to Tyr) and E7 (His to Gln) reduce O(2) and CO affinity.
- Mutants exhibit significantly decreased reactivity toward nitric oxide (NO).
- Kinetic heterogeneity between alpha and beta chains in Hb(YQ) was observed and structurally rationalized.
Conclusions:
- Specific distal side mutations effectively modulate hemoglobin's ligand-binding properties.
- These engineered hemoglobins show promise for blood substitute development due to altered reactivity.
- Crystallographic data provide insights into initial ligand binding events in the T-state mutant.